Market News AIOpen the app

UBS cut its price target for Braskem to $0.75 from $1.50 and still says to sell.

OpinionRead the original at marketscreener.com
Bad for BAK

UBS cut its target for Braskem shares in half and kept its Sell rating. This is an analyst's view, not a report of new company results.

BAK · Braskem S.A.

AI read · Bad for BAK

The AI's read

That points to less confidence in what Braskem's shares may be worth. The report gives no new sales, profit, or operating data, so this warning comes from UBS's view, not a reported change in Braskem's business.

Get alerts for BAK

Follow Braskem S.A. (BAK) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BAK
Free on the App Store and Google Play, or on the web.